Marshall Wace North America’s CryoPort CYRX Stock Holding History

Marshall Wace North America’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.1M	Sell	16,599 -10,390	-38%	-$641K	﹤0.01%	887
2021 Q2	$1.7M	Buy	+26,989	New	+$1.52M	0.01%	857
2021 Q1	–	Sell	-24,642	Closed	-$1.08M	–	1556
2020 Q4	$1.08M	Sell	24,642 -18,756	-43%	-$893K	﹤0.01%	929
2020 Q3	$2.06M	Buy	+43,398	New	+$1.76M	0.01%	577
2019 Q3	–	Sell	-51,342	Closed	-$941K	–	1345
2019 Q2	$941K	Buy	+51,342	New	+$815K	0.01%	770
2019 Q1	–	Sell	-460	Closed	-$5K	–	1629
2018 Q4	$5K	Buy	+460	New	+$5K	﹤0.01%	1436

Other funds holding CYRX

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Marshall Wace North America's CYRX Position: Q3 2021 in Review

Marshall Wace North America reduced its CryoPort (CYRX) stake by 38% in Q3 2021, selling an estimated $641K and leaving 16,599 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Marshall Wace North America first reported a position in CYRX in Q4 2018 and has held it in 6 quarters since. The position peaked at $2.06M in Q3 2020. 209 funds tracked by Wall St. Rank hold CYRX as of Q3 2021.

Marshall Wace North America held 16,599 shares of CryoPort worth $1.1M as of Q3 2021.
Marshall Wace North America sold 10,390 CryoPort shares in Q3 2021, an estimated $641K.
CryoPort made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #887 holding.
Marshall Wace North America first reported a position in CryoPort in Q4 2018 and has held it in 6 quarters since.
Marshall Wace North America's CryoPort position peaked at $2.06M in Q3 2020.
209 funds tracked by Wall St. Rank held CryoPort as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.